Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-08

AUTHORS

Fatima Rangwala, Johanna C. Bendell, Mark F. Kozloff, Christy C. Arrowood, Andrew Dellinger, Jennifer Meadows, Sandra Tourt-Uhlig, Jennifer Murphy, Kellen L. Meadows, Aijing Starr, Samuel Broderick, John C. Brady, Stephanie M. Cushman, Michael A. Morse, Hope E. Uronis, S. David Hsu, S. Yousuf Zafar, James Wallace, Alexander N. Starodub, John H. Strickler, Herbert Pang, Andrew B. Nixon, Herbert I. Hurwitz

ABSTRACT

PURPOSE: To define maximum tolerated dose (MTD), toxicities, and pharmacodynamics of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumor patients. DESIGN: This was a standard "3 + 3" dose-escalation trial. All subjects received bevacizumab 7.5 mg/kg on day 1 of each cycle. Doses for capecitabine, oxaliplatin and everolimus were modified per dose limiting toxicity (DLT). Baseline and on-treatment plasma biomarkers were analyzed. Archived tumor mRNA levels were evaluated for NRP1, NRP2 and VEGF-A isoforms. RESULTS: Twenty-nine patients were evaluable for toxicity and 30 for efficacy. Two DLTs were observed in cohort 1 and one DLT each was observed in cohort -1 and -1b. Grade ≥3 toxicities included neutropenia, hypertension, perforation/fistula/hemorrhage, hypertriglyceridemia, diarrhea, and thromboembolism. Twelve subjects experienced partial response (PR); 12 had stable disease as best response. Three of seven chemorefractory metastatic colorectal cancer (mCRC) subjects experienced PR; 8 of 15 chemonaive mCRC subjects experienced PR. Plasma TβRIII and IL-6 increased on treatment but without correlation to outcome. Increased VEGF165 levels significantly correlated with longer progression free survival. CONCLUSIONS: Everolimus with full dose capecitabine, oxaliplatin, and bevacizumab had unacceptable toxicity. MTD was: everolimus 5 mg daily; capecitabine 680 mg/m(2) BID days 1-14; oxaliplatin 100 mg/m(2) and bevacizumab 7.5 mg/kg, day 1. Activity was noted in mCRC. More... »

PAGES

700-709

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10637-014-0089-2

DOI

http://dx.doi.org/10.1007/s10637-014-0089-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011851236

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24711126


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Maximum Tolerated Dose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuropilin-1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuropilin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rangwala", 
        "givenName": "Fatima", 
        "id": "sg:person.01056564310.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056564310.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sarah Cannon", 
          "id": "https://www.grid.ac/institutes/grid.419513.b", 
          "name": [
            "Sarah Cannon Research Institute, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bendell", 
        "givenName": "Johanna C.", 
        "id": "sg:person.01174064377.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174064377.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ingalls Memorial Hospital/Cancer Research Center, Harvey, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kozloff", 
        "givenName": "Mark F.", 
        "id": "sg:person.01004472265.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004472265.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arrowood", 
        "givenName": "Christy C.", 
        "id": "sg:person.0701212230.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701212230.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.414179.e", 
          "name": [
            "Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dellinger", 
        "givenName": "Andrew", 
        "id": "sg:person.01032223373.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032223373.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meadows", 
        "givenName": "Jennifer", 
        "id": "sg:person.0670656642.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670656642.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Duke Clinical Research Institute, 27705, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tourt-Uhlig", 
        "givenName": "Sandra", 
        "id": "sg:person.07713414457.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07713414457.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Duke Clinical Research Institute, 27705, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murphy", 
        "givenName": "Jennifer", 
        "id": "sg:person.01005105242.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005105242.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meadows", 
        "givenName": "Kellen L.", 
        "id": "sg:person.014460031617.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Clinical Research Institute, 27705, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Starr", 
        "givenName": "Aijing", 
        "id": "sg:person.0755147066.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755147066.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Duke Clinical Research Institute, 27705, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Broderick", 
        "givenName": "Samuel", 
        "id": "sg:person.01103541444.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103541444.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brady", 
        "givenName": "John C.", 
        "id": "sg:person.01200002430.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200002430.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cushman", 
        "givenName": "Stephanie M.", 
        "id": "sg:person.01325152473.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325152473.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "Michael A.", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uronis", 
        "givenName": "Hope E.", 
        "id": "sg:person.01257037273.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257037273.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "S. David", 
        "id": "sg:person.0627370707.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627370707.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zafar", 
        "givenName": "S. Yousuf", 
        "id": "sg:person.01110705575.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110705575.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ingalls Memorial Hospital/Cancer Research Center, Harvey, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wallace", 
        "givenName": "James", 
        "id": "sg:person.01241401317.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241401317.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Goshen Health", 
          "id": "https://www.grid.ac/institutes/grid.490115.8", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA", 
            "Goshen Center for Cancer Care, 46526, Goshen, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Starodub", 
        "givenName": "Alexander N.", 
        "id": "sg:person.013456341506.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013456341506.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strickler", 
        "givenName": "John H.", 
        "id": "sg:person.01076437332.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076437332.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.414179.e", 
          "name": [
            "Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pang", 
        "givenName": "Herbert", 
        "id": "sg:person.0675044633.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675044633.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nixon", 
        "givenName": "Andrew B.", 
        "id": "sg:person.01055010121.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055010121.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hurwitz", 
        "givenName": "Herbert I.", 
        "id": "sg:person.01242177577.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ccr.2006.07.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001389206"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.22.20.7004-7014.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003444276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.0766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006224899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa061884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008302687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.2440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008387745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/carcin/bgm249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009626914"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009929890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61904-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010511397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-012-1911-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011070767", 
          "https://doi.org/10.1007/s00280-012-1911-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3152", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012938435"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013847179", 
          "https://doi.org/10.1038/nrc2442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014051315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-012-1889-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014306924", 
          "https://doi.org/10.1007/s00280-012-1889-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0202-128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015189512", 
          "https://doi.org/10.1038/nm0202-128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0202-128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015189512", 
          "https://doi.org/10.1038/nm0202-128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016821519", 
          "https://doi.org/10.1038/nrc2664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016821519", 
          "https://doi.org/10.1038/nrc2664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-2825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022578866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1507-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024060636", 
          "https://doi.org/10.1007/s00280-010-1507-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-0926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025140550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2009-0071", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025282999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cam4.71", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026922925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1307-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029072898", 
          "https://doi.org/10.1007/s00280-010-1307-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-010-1307-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029072898", 
          "https://doi.org/10.1007/s00280-010-1307-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.9930", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029489307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-009-0818-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030939138", 
          "https://doi.org/10.1007/s00384-009-0818-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-009-0818-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030939138", 
          "https://doi.org/10.1007/s00384-009-0818-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-009-0818-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030939138", 
          "https://doi.org/10.1007/s00384-009-0818-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033031313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-2007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033901975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci29293", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035506455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035733470", 
          "https://doi.org/10.1038/nature05029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035733470", 
          "https://doi.org/10.1038/nature05029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2011-0078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036849899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cellsig.2010.01.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038115007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70241-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040116470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.9824", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044159457"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2008.01.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045254265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048649001", 
          "https://doi.org/10.1038/sj.onc.1205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048649001", 
          "https://doi.org/10.1038/sj.onc.1205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-2684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050663123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-2057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051117294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.69", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052460632", 
          "https://doi.org/10.1038/bjc.2013.69"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.10.066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075108936", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.29.15_suppl.10508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083946985"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08", 
    "datePublishedReg": "2014-08-01", 
    "description": "PURPOSE: To define maximum tolerated dose (MTD), toxicities, and pharmacodynamics of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumor patients.\nDESIGN: This was a standard \"3\u2009+\u20093\" dose-escalation trial. All subjects received bevacizumab 7.5 mg/kg on day 1 of each cycle. Doses for capecitabine, oxaliplatin and everolimus were modified per dose limiting toxicity (DLT). Baseline and on-treatment plasma biomarkers were analyzed. Archived tumor mRNA levels were evaluated for NRP1, NRP2 and VEGF-A isoforms.\nRESULTS: Twenty-nine patients were evaluable for toxicity and 30 for efficacy. Two DLTs were observed in cohort 1 and one DLT each was observed in cohort -1 and -1b. Grade \u22653 toxicities included neutropenia, hypertension, perforation/fistula/hemorrhage, hypertriglyceridemia, diarrhea, and thromboembolism. Twelve subjects experienced partial response (PR); 12 had stable disease as best response. Three of seven chemorefractory metastatic colorectal cancer (mCRC) subjects experienced PR; 8 of 15 chemonaive mCRC subjects experienced PR. Plasma T\u03b2RIII and IL-6 increased on treatment but without correlation to outcome. Increased VEGF165 levels significantly correlated with longer progression free survival.\nCONCLUSIONS: Everolimus with full dose capecitabine, oxaliplatin, and bevacizumab had unacceptable toxicity. MTD was: everolimus 5 mg daily; capecitabine 680 mg/m(2) BID days 1-14; oxaliplatin 100 mg/m(2) and bevacizumab 7.5 mg/kg, day 1. Activity was noted in mCRC.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10637-014-0089-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438807", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2420933", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "name": "Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors", 
    "pagination": "700-709", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "38772f055986932419e22c34b614d3b84ea33efaa5ee5a99eafefe1e1b9dda46"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24711126"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10637-014-0089-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011851236"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10637-014-0089-2", 
      "https://app.dimensions.ai/details/publication/pub.1011851236"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000511.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10637-014-0089-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0089-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0089-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0089-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10637-014-0089-2'


 

This table displays all metadata directly associated to this object as RDF triples.

468 TRIPLES      21 PREDICATES      92 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10637-014-0089-2 schema:about N01c9a20e027c4ce29c555ecd00d95a51
2 N08bf1938242a46cf95846e864da91878
3 N0ab81f3848fb4c23baab347d0179fc2a
4 N10f71bfefaec4213b09e9bb00fa7e437
5 N4b0ff2677dee41248f0333236fd93342
6 N4c2212e085894d46b32c484dd02cd464
7 N5d2db964342746e4b8b7b0719e0d6e1c
8 N5eb6b198c46440b2af18d3d76efff2aa
9 N61dc96c537cf485a8237041676b137a6
10 N64038bc6123146e28e23f8a1f223c6aa
11 N6f4e7f58f730498fadd98fec95e938d8
12 N756372d6118849e5987c0854b3a7cbf9
13 N75d848a47e90465592116d45befd8e2e
14 N84cefc222c7a41fd873ddf251dadd71f
15 N987a146a959e449fbb5768f30553e863
16 Na09bea185d4045b39ad8cdd7ee3055cd
17 Nab54d1694b2a4397887c2897bdfdcda6
18 Nab69b557884e4a12a7caacd73640e542
19 Nc57b3c2c66164220af3c78aa50290dc3
20 Ncee37f3688814c7eb81fdd1a3a2fa090
21 Ncfd13edcad45413bb6fa7babd223ba5a
22 Nd66563efe9ca419aabddd39f40adcd97
23 Nd70d3b886bf544a6a7e2831524711ff1
24 Nf64dc4e9124b49a886ddba356063232b
25 anzsrc-for:11
26 anzsrc-for:1112
27 schema:author Nd13439a23d424e2fa908c2306c5a370e
28 schema:citation sg:pub.10.1007/s00280-010-1307-z
29 sg:pub.10.1007/s00280-010-1507-6
30 sg:pub.10.1007/s00280-012-1889-8
31 sg:pub.10.1007/s00280-012-1911-1
32 sg:pub.10.1007/s00384-009-0818-8
33 sg:pub.10.1038/bjc.2013.69
34 sg:pub.10.1038/nature05029
35 sg:pub.10.1038/nm0202-128
36 sg:pub.10.1038/nrc2442
37 sg:pub.10.1038/nrc2664
38 sg:pub.10.1038/sj.onc.1205439
39 https://app.dimensions.ai/details/publication/pub.1075108936
40 https://doi.org/10.1002/cam4.71
41 https://doi.org/10.1002/cncr.25320
42 https://doi.org/10.1016/j.ccr.2006.07.003
43 https://doi.org/10.1016/j.ccr.2008.01.034
44 https://doi.org/10.1016/j.cellsig.2010.01.016
45 https://doi.org/10.1016/s0140-6736(07)61904-7
46 https://doi.org/10.1016/s1470-2045(12)70241-3
47 https://doi.org/10.1056/nejmoa032691
48 https://doi.org/10.1056/nejmoa061884
49 https://doi.org/10.1093/carcin/bgm249
50 https://doi.org/10.1128/mcb.22.20.7004-7014.2002
51 https://doi.org/10.1158/0008-5472.can-05-2825
52 https://doi.org/10.1158/0008-5472.can-08-2007
53 https://doi.org/10.1158/0008-5472.can-11-2684
54 https://doi.org/10.1158/1078-0432.ccr-08-2057
55 https://doi.org/10.1158/1078-0432.ccr-11-0945
56 https://doi.org/10.1158/1078-0432.ccr-13-0926
57 https://doi.org/10.1172/jci29293
58 https://doi.org/10.1200/jco.2003.10.066
59 https://doi.org/10.1200/jco.2007.12.2440
60 https://doi.org/10.1200/jco.2007.14.9930
61 https://doi.org/10.1200/jco.2008.20.0766
62 https://doi.org/10.1200/jco.2009.26.3152
63 https://doi.org/10.1200/jco.2011.29.15_suppl.10508
64 https://doi.org/10.1200/jco.2011.39.9824
65 https://doi.org/10.1634/theoncologist.2009-0071
66 https://doi.org/10.1634/theoncologist.2011-0078
67 schema:datePublished 2014-08
68 schema:datePublishedReg 2014-08-01
69 schema:description PURPOSE: To define maximum tolerated dose (MTD), toxicities, and pharmacodynamics of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumor patients. DESIGN: This was a standard "3 + 3" dose-escalation trial. All subjects received bevacizumab 7.5 mg/kg on day 1 of each cycle. Doses for capecitabine, oxaliplatin and everolimus were modified per dose limiting toxicity (DLT). Baseline and on-treatment plasma biomarkers were analyzed. Archived tumor mRNA levels were evaluated for NRP1, NRP2 and VEGF-A isoforms. RESULTS: Twenty-nine patients were evaluable for toxicity and 30 for efficacy. Two DLTs were observed in cohort 1 and one DLT each was observed in cohort -1 and -1b. Grade ≥3 toxicities included neutropenia, hypertension, perforation/fistula/hemorrhage, hypertriglyceridemia, diarrhea, and thromboembolism. Twelve subjects experienced partial response (PR); 12 had stable disease as best response. Three of seven chemorefractory metastatic colorectal cancer (mCRC) subjects experienced PR; 8 of 15 chemonaive mCRC subjects experienced PR. Plasma TβRIII and IL-6 increased on treatment but without correlation to outcome. Increased VEGF165 levels significantly correlated with longer progression free survival. CONCLUSIONS: Everolimus with full dose capecitabine, oxaliplatin, and bevacizumab had unacceptable toxicity. MTD was: everolimus 5 mg daily; capecitabine 680 mg/m(2) BID days 1-14; oxaliplatin 100 mg/m(2) and bevacizumab 7.5 mg/kg, day 1. Activity was noted in mCRC.
70 schema:genre research_article
71 schema:inLanguage en
72 schema:isAccessibleForFree true
73 schema:isPartOf N38e34e16386246e0b60ef0104d6e2fe3
74 Nae4203ea49754f5383534158d5c3f5bf
75 sg:journal.1094201
76 schema:name Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
77 schema:pagination 700-709
78 schema:productId N7b2e5b03a20e4894bd5d7652f36d7f1a
79 N7fab41c6e787421b821006e231a72dfa
80 N8be6e378e71b4e858504b103930d2227
81 N9a8ba2c1e53845cabf845ae06a7cb08b
82 Nb9567d5c513641588cdc3792649438e0
83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011851236
84 https://doi.org/10.1007/s10637-014-0089-2
85 schema:sdDatePublished 2019-04-11T02:00
86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
87 schema:sdPublisher N6e185c2e4c32437192e7c19d26fcb28d
88 schema:url http://link.springer.com/10.1007%2Fs10637-014-0089-2
89 sgo:license sg:explorer/license/
90 sgo:sdDataset articles
91 rdf:type schema:ScholarlyArticle
92 N01c9a20e027c4ce29c555ecd00d95a51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Antimetabolites, Antineoplastic
94 rdf:type schema:DefinedTerm
95 N0274fad33aaa4e96a2772351c225c29a rdf:first sg:person.01174064377.38
96 rdf:rest N1e4f11ca6cdf421b91f72a52d8fefc2f
97 N08bf1938242a46cf95846e864da91878 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Fluorouracil
99 rdf:type schema:DefinedTerm
100 N0ab81f3848fb4c23baab347d0179fc2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Immunosuppressive Agents
102 rdf:type schema:DefinedTerm
103 N10f71bfefaec4213b09e9bb00fa7e437 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Vascular Endothelial Growth Factor A
105 rdf:type schema:DefinedTerm
106 N1e4f11ca6cdf421b91f72a52d8fefc2f rdf:first sg:person.01004472265.49
107 rdf:rest N8fb6b223a99743939df49958d43c2895
108 N1f99cbd5b28c4fafb01141eeec4eaded rdf:first sg:person.01055010121.15
109 rdf:rest Nc1d03de15323412e9a25dc0419859f69
110 N21be52348f404374b033c3a408159277 schema:name Ingalls Memorial Hospital/Cancer Research Center, Harvey, IL, USA
111 rdf:type schema:Organization
112 N24ba76d5d86349369db9350a088526d6 rdf:first sg:person.013456341506.33
113 rdf:rest N9860e595757d4d569f2f83c899fa11d9
114 N327c883e1a544e2e837c618e8567e868 rdf:first sg:person.014460031617.65
115 rdf:rest N864e8b6433f6453b97645b03ea843789
116 N3750593b73a748a49a766cc2414a8e9e rdf:first sg:person.01241401317.10
117 rdf:rest N24ba76d5d86349369db9350a088526d6
118 N38e34e16386246e0b60ef0104d6e2fe3 schema:volumeNumber 32
119 rdf:type schema:PublicationVolume
120 N4b0ff2677dee41248f0333236fd93342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Angiogenesis Inhibitors
122 rdf:type schema:DefinedTerm
123 N4c2212e085894d46b32c484dd02cd464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Maximum Tolerated Dose
125 rdf:type schema:DefinedTerm
126 N55c68dd2f5b7414594583ce01901fd84 rdf:first sg:person.01005105242.15
127 rdf:rest N327c883e1a544e2e837c618e8567e868
128 N56eb585baa4c4b329ab04da1df3d9d69 rdf:first sg:person.01032223373.33
129 rdf:rest Nb4ff22d2198048d1ae5e2317571fd500
130 N5d2db964342746e4b8b7b0719e0d6e1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Capecitabine
132 rdf:type schema:DefinedTerm
133 N5eb6b198c46440b2af18d3d76efff2aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Neoplasms
135 rdf:type schema:DefinedTerm
136 N61dc96c537cf485a8237041676b137a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Sirolimus
138 rdf:type schema:DefinedTerm
139 N64038bc6123146e28e23f8a1f223c6aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Antineoplastic Combined Chemotherapy Protocols
141 rdf:type schema:DefinedTerm
142 N6e185c2e4c32437192e7c19d26fcb28d schema:name Springer Nature - SN SciGraph project
143 rdf:type schema:Organization
144 N6f4e7f58f730498fadd98fec95e938d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name RNA, Messenger
146 rdf:type schema:DefinedTerm
147 N72afee3696704c34b428b0446145556a rdf:first sg:person.01110705575.00
148 rdf:rest N3750593b73a748a49a766cc2414a8e9e
149 N756372d6118849e5987c0854b3a7cbf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Male
151 rdf:type schema:DefinedTerm
152 N75d848a47e90465592116d45befd8e2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Biomarkers, Tumor
154 rdf:type schema:DefinedTerm
155 N7b2e5b03a20e4894bd5d7652f36d7f1a schema:name pubmed_id
156 schema:value 24711126
157 rdf:type schema:PropertyValue
158 N7fab41c6e787421b821006e231a72dfa schema:name readcube_id
159 schema:value 38772f055986932419e22c34b614d3b84ea33efaa5ee5a99eafefe1e1b9dda46
160 rdf:type schema:PropertyValue
161 N84cefc222c7a41fd873ddf251dadd71f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Bevacizumab
163 rdf:type schema:DefinedTerm
164 N864e8b6433f6453b97645b03ea843789 rdf:first sg:person.0755147066.88
165 rdf:rest Ndcba79add7214b36ae43598aaaca0402
166 N8babab3426eb4c0da0b91a4bb63e3430 rdf:first sg:person.0627370707.41
167 rdf:rest N72afee3696704c34b428b0446145556a
168 N8be6e378e71b4e858504b103930d2227 schema:name dimensions_id
169 schema:value pub.1011851236
170 rdf:type schema:PropertyValue
171 N8fb6b223a99743939df49958d43c2895 rdf:first sg:person.0701212230.71
172 rdf:rest N56eb585baa4c4b329ab04da1df3d9d69
173 N9860e595757d4d569f2f83c899fa11d9 rdf:first sg:person.01076437332.24
174 rdf:rest N996154b6765a4960946bd2213b59e18c
175 N987a146a959e449fbb5768f30553e863 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Antibodies, Monoclonal, Humanized
177 rdf:type schema:DefinedTerm
178 N996154b6765a4960946bd2213b59e18c rdf:first sg:person.0675044633.36
179 rdf:rest N1f99cbd5b28c4fafb01141eeec4eaded
180 N9a8ba2c1e53845cabf845ae06a7cb08b schema:name doi
181 schema:value 10.1007/s10637-014-0089-2
182 rdf:type schema:PropertyValue
183 Na09bea185d4045b39ad8cdd7ee3055cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Neuropilin-1
185 rdf:type schema:DefinedTerm
186 Nab54d1694b2a4397887c2897bdfdcda6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Everolimus
188 rdf:type schema:DefinedTerm
189 Nab69b557884e4a12a7caacd73640e542 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Humans
191 rdf:type schema:DefinedTerm
192 Nae4203ea49754f5383534158d5c3f5bf schema:issueNumber 4
193 rdf:type schema:PublicationIssue
194 Nae5127a456fa43e78aa2f7a6a6a73ec7 rdf:first sg:person.013700705377.06
195 rdf:rest Ne6cb04fe81754bd8be1c17884bfcf2a4
196 Nb4ff22d2198048d1ae5e2317571fd500 rdf:first sg:person.0670656642.21
197 rdf:rest Nd718e85f898b47e9a5b119a4c8ed3232
198 Nb9567d5c513641588cdc3792649438e0 schema:name nlm_unique_id
199 schema:value 8309330
200 rdf:type schema:PropertyValue
201 Nc1d03de15323412e9a25dc0419859f69 rdf:first sg:person.01242177577.68
202 rdf:rest rdf:nil
203 Nc57b3c2c66164220af3c78aa50290dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Female
205 rdf:type schema:DefinedTerm
206 Ncb60c3a9c4be44a1b9c854d6d3987350 rdf:first sg:person.01325152473.50
207 rdf:rest Nae5127a456fa43e78aa2f7a6a6a73ec7
208 Ncee37f3688814c7eb81fdd1a3a2fa090 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Neuropilin-2
210 rdf:type schema:DefinedTerm
211 Ncfd13edcad45413bb6fa7babd223ba5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Antineoplastic Agents
213 rdf:type schema:DefinedTerm
214 Nd13439a23d424e2fa908c2306c5a370e rdf:first sg:person.01056564310.61
215 rdf:rest N0274fad33aaa4e96a2772351c225c29a
216 Nd66563efe9ca419aabddd39f40adcd97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Organoplatinum Compounds
218 rdf:type schema:DefinedTerm
219 Nd70d3b886bf544a6a7e2831524711ff1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Middle Aged
221 rdf:type schema:DefinedTerm
222 Nd718e85f898b47e9a5b119a4c8ed3232 rdf:first sg:person.07713414457.10
223 rdf:rest N55c68dd2f5b7414594583ce01901fd84
224 Nd78ff750d03d4bebb327a5bd90c193b8 rdf:first sg:person.01200002430.43
225 rdf:rest Ncb60c3a9c4be44a1b9c854d6d3987350
226 Ndcba79add7214b36ae43598aaaca0402 rdf:first sg:person.01103541444.51
227 rdf:rest Nd78ff750d03d4bebb327a5bd90c193b8
228 Ne6cb04fe81754bd8be1c17884bfcf2a4 rdf:first sg:person.01257037273.91
229 rdf:rest N8babab3426eb4c0da0b91a4bb63e3430
230 Nf64dc4e9124b49a886ddba356063232b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Deoxycytidine
232 rdf:type schema:DefinedTerm
233 Nf83a85a85cc04842a8b2bd3bba22551a schema:name Ingalls Memorial Hospital/Cancer Research Center, Harvey, IL, USA
234 rdf:type schema:Organization
235 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
236 schema:name Medical and Health Sciences
237 rdf:type schema:DefinedTerm
238 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
239 schema:name Oncology and Carcinogenesis
240 rdf:type schema:DefinedTerm
241 sg:grant.2420933 http://pending.schema.org/fundedItem sg:pub.10.1007/s10637-014-0089-2
242 rdf:type schema:MonetaryGrant
243 sg:grant.2438807 http://pending.schema.org/fundedItem sg:pub.10.1007/s10637-014-0089-2
244 rdf:type schema:MonetaryGrant
245 sg:journal.1094201 schema:issn 0167-6997
246 1573-0646
247 schema:name Investigational New Drugs
248 rdf:type schema:Periodical
249 sg:person.01004472265.49 schema:affiliation Nf83a85a85cc04842a8b2bd3bba22551a
250 schema:familyName Kozloff
251 schema:givenName Mark F.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004472265.49
253 rdf:type schema:Person
254 sg:person.01005105242.15 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
255 schema:familyName Murphy
256 schema:givenName Jennifer
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005105242.15
258 rdf:type schema:Person
259 sg:person.01032223373.33 schema:affiliation https://www.grid.ac/institutes/grid.414179.e
260 schema:familyName Dellinger
261 schema:givenName Andrew
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032223373.33
263 rdf:type schema:Person
264 sg:person.01055010121.15 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
265 schema:familyName Nixon
266 schema:givenName Andrew B.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055010121.15
268 rdf:type schema:Person
269 sg:person.01056564310.61 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
270 schema:familyName Rangwala
271 schema:givenName Fatima
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056564310.61
273 rdf:type schema:Person
274 sg:person.01076437332.24 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
275 schema:familyName Strickler
276 schema:givenName John H.
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076437332.24
278 rdf:type schema:Person
279 sg:person.01103541444.51 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
280 schema:familyName Broderick
281 schema:givenName Samuel
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103541444.51
283 rdf:type schema:Person
284 sg:person.01110705575.00 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
285 schema:familyName Zafar
286 schema:givenName S. Yousuf
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110705575.00
288 rdf:type schema:Person
289 sg:person.01174064377.38 schema:affiliation https://www.grid.ac/institutes/grid.419513.b
290 schema:familyName Bendell
291 schema:givenName Johanna C.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174064377.38
293 rdf:type schema:Person
294 sg:person.01200002430.43 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
295 schema:familyName Brady
296 schema:givenName John C.
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200002430.43
298 rdf:type schema:Person
299 sg:person.01241401317.10 schema:affiliation N21be52348f404374b033c3a408159277
300 schema:familyName Wallace
301 schema:givenName James
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241401317.10
303 rdf:type schema:Person
304 sg:person.01242177577.68 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
305 schema:familyName Hurwitz
306 schema:givenName Herbert I.
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242177577.68
308 rdf:type schema:Person
309 sg:person.01257037273.91 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
310 schema:familyName Uronis
311 schema:givenName Hope E.
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257037273.91
313 rdf:type schema:Person
314 sg:person.01325152473.50 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
315 schema:familyName Cushman
316 schema:givenName Stephanie M.
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325152473.50
318 rdf:type schema:Person
319 sg:person.013456341506.33 schema:affiliation https://www.grid.ac/institutes/grid.490115.8
320 schema:familyName Starodub
321 schema:givenName Alexander N.
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013456341506.33
323 rdf:type schema:Person
324 sg:person.013700705377.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
325 schema:familyName Morse
326 schema:givenName Michael A.
327 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
328 rdf:type schema:Person
329 sg:person.014460031617.65 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
330 schema:familyName Meadows
331 schema:givenName Kellen L.
332 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014460031617.65
333 rdf:type schema:Person
334 sg:person.0627370707.41 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
335 schema:familyName Hsu
336 schema:givenName S. David
337 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627370707.41
338 rdf:type schema:Person
339 sg:person.0670656642.21 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
340 schema:familyName Meadows
341 schema:givenName Jennifer
342 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670656642.21
343 rdf:type schema:Person
344 sg:person.0675044633.36 schema:affiliation https://www.grid.ac/institutes/grid.414179.e
345 schema:familyName Pang
346 schema:givenName Herbert
347 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675044633.36
348 rdf:type schema:Person
349 sg:person.0701212230.71 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
350 schema:familyName Arrowood
351 schema:givenName Christy C.
352 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701212230.71
353 rdf:type schema:Person
354 sg:person.0755147066.88 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
355 schema:familyName Starr
356 schema:givenName Aijing
357 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755147066.88
358 rdf:type schema:Person
359 sg:person.07713414457.10 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
360 schema:familyName Tourt-Uhlig
361 schema:givenName Sandra
362 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07713414457.10
363 rdf:type schema:Person
364 sg:pub.10.1007/s00280-010-1307-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1029072898
365 https://doi.org/10.1007/s00280-010-1307-z
366 rdf:type schema:CreativeWork
367 sg:pub.10.1007/s00280-010-1507-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024060636
368 https://doi.org/10.1007/s00280-010-1507-6
369 rdf:type schema:CreativeWork
370 sg:pub.10.1007/s00280-012-1889-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014306924
371 https://doi.org/10.1007/s00280-012-1889-8
372 rdf:type schema:CreativeWork
373 sg:pub.10.1007/s00280-012-1911-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011070767
374 https://doi.org/10.1007/s00280-012-1911-1
375 rdf:type schema:CreativeWork
376 sg:pub.10.1007/s00384-009-0818-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030939138
377 https://doi.org/10.1007/s00384-009-0818-8
378 rdf:type schema:CreativeWork
379 sg:pub.10.1038/bjc.2013.69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052460632
380 https://doi.org/10.1038/bjc.2013.69
381 rdf:type schema:CreativeWork
382 sg:pub.10.1038/nature05029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035733470
383 https://doi.org/10.1038/nature05029
384 rdf:type schema:CreativeWork
385 sg:pub.10.1038/nm0202-128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015189512
386 https://doi.org/10.1038/nm0202-128
387 rdf:type schema:CreativeWork
388 sg:pub.10.1038/nrc2442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013847179
389 https://doi.org/10.1038/nrc2442
390 rdf:type schema:CreativeWork
391 sg:pub.10.1038/nrc2664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016821519
392 https://doi.org/10.1038/nrc2664
393 rdf:type schema:CreativeWork
394 sg:pub.10.1038/sj.onc.1205439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048649001
395 https://doi.org/10.1038/sj.onc.1205439
396 rdf:type schema:CreativeWork
397 https://app.dimensions.ai/details/publication/pub.1075108936 schema:CreativeWork
398 https://doi.org/10.1002/cam4.71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026922925
399 rdf:type schema:CreativeWork
400 https://doi.org/10.1002/cncr.25320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009929890
401 rdf:type schema:CreativeWork
402 https://doi.org/10.1016/j.ccr.2006.07.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001389206
403 rdf:type schema:CreativeWork
404 https://doi.org/10.1016/j.ccr.2008.01.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045254265
405 rdf:type schema:CreativeWork
406 https://doi.org/10.1016/j.cellsig.2010.01.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038115007
407 rdf:type schema:CreativeWork
408 https://doi.org/10.1016/s0140-6736(07)61904-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010511397
409 rdf:type schema:CreativeWork
410 https://doi.org/10.1016/s1470-2045(12)70241-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040116470
411 rdf:type schema:CreativeWork
412 https://doi.org/10.1056/nejmoa032691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014051315
413 rdf:type schema:CreativeWork
414 https://doi.org/10.1056/nejmoa061884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008302687
415 rdf:type schema:CreativeWork
416 https://doi.org/10.1093/carcin/bgm249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009626914
417 rdf:type schema:CreativeWork
418 https://doi.org/10.1128/mcb.22.20.7004-7014.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003444276
419 rdf:type schema:CreativeWork
420 https://doi.org/10.1158/0008-5472.can-05-2825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022578866
421 rdf:type schema:CreativeWork
422 https://doi.org/10.1158/0008-5472.can-08-2007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033901975
423 rdf:type schema:CreativeWork
424 https://doi.org/10.1158/0008-5472.can-11-2684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050663123
425 rdf:type schema:CreativeWork
426 https://doi.org/10.1158/1078-0432.ccr-08-2057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051117294
427 rdf:type schema:CreativeWork
428 https://doi.org/10.1158/1078-0432.ccr-11-0945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033031313
429 rdf:type schema:CreativeWork
430 https://doi.org/10.1158/1078-0432.ccr-13-0926 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025140550
431 rdf:type schema:CreativeWork
432 https://doi.org/10.1172/jci29293 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035506455
433 rdf:type schema:CreativeWork
434 https://doi.org/10.1200/jco.2003.10.066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203899
435 rdf:type schema:CreativeWork
436 https://doi.org/10.1200/jco.2007.12.2440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008387745
437 rdf:type schema:CreativeWork
438 https://doi.org/10.1200/jco.2007.14.9930 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029489307
439 rdf:type schema:CreativeWork
440 https://doi.org/10.1200/jco.2008.20.0766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006224899
441 rdf:type schema:CreativeWork
442 https://doi.org/10.1200/jco.2009.26.3152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012938435
443 rdf:type schema:CreativeWork
444 https://doi.org/10.1200/jco.2011.29.15_suppl.10508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083946985
445 rdf:type schema:CreativeWork
446 https://doi.org/10.1200/jco.2011.39.9824 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044159457
447 rdf:type schema:CreativeWork
448 https://doi.org/10.1634/theoncologist.2009-0071 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025282999
449 rdf:type schema:CreativeWork
450 https://doi.org/10.1634/theoncologist.2011-0078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036849899
451 rdf:type schema:CreativeWork
452 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
453 schema:name Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
454 rdf:type schema:Organization
455 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
456 schema:name Duke Clinical Research Institute, 27705, Durham, NC, USA
457 Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
458 rdf:type schema:Organization
459 https://www.grid.ac/institutes/grid.414179.e schema:alternateName Duke Medical Center
460 schema:name Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA
461 rdf:type schema:Organization
462 https://www.grid.ac/institutes/grid.419513.b schema:alternateName Sarah Cannon
463 schema:name Sarah Cannon Research Institute, Nashville, TN, USA
464 rdf:type schema:Organization
465 https://www.grid.ac/institutes/grid.490115.8 schema:alternateName Goshen Health
466 schema:name Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, 27710, Durham, NC, USA
467 Goshen Center for Cancer Care, 46526, Goshen, IN, USA
468 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...